US Patent Family Members and Approved Drugs for Canada Patent: 2094275
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: CA2094275
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,372,808 | 2011-12-13 | interferon alfacon-1 | Kadmon Pharmaceuticals Llc | INFERGEN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
